Switch View
© EQS Newswire
01.10.2025
ISIN: CH0012627250
HBM Healthcare Investments AG
HBMN
LISTED
SIX
HBM Healthcare Investments erzielt ein starkes Quartalsergebnis – NAV steigt im zweiten Quartal des Geschäftsjahres 2025/2026 um 16,4 Prozent
News Preview
HBM Healthcare Investments verzeichnete im zweiten Quartal des Geschäftsjahres 2025/2026 eine überzeugende Performance und steigerte den Nettoinventarwert (NAV) je Aktie um 16,4 Prozent auf CHF 251.78. Daraus resultierte ein Quartalsgewinn von CHF 236 Millionen, womit der hauptsächlich währungsbedingte Verlust aus dem ersten Quartal mehr als kompen......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.10.2025
ISIN: CH0012627250
HBM Healthcare Investments AG
HBMN
LISTED
SIX
HBM Healthcare Investments reports strong quarterly results – NAV rises by 16.4 per cent in the second quarter of the 2025/2026 financial year
News Preview
HBM Healthcare Investments delivered a convincing performance in the second quarter of the 2025/2026 financial year, increasing its net asset value (NAV) per share by 16.4 per cent to CHF 251.78. This resulted in a quarterly profit of CHF 236 million, more than offsetting the primarily currency-related loss from the first quarter.
For ......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.10.2025
ISIN: CH0012627250
HBM Healthcare Investments AG
HBMN
LISTED
SIX
Key Figures
30.09.2025
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
30.09.2025
01.10.2025 / 17:47 CET/CEST
in CHF
Performance in %
30.09.2025
MTD
FYTD
CYTD
NAV
251.78
4.6
6.1
......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
01.10.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
More Unhoused Seniors in Los Angeles County will Find a Home and Access Healthcare Thanks to a $7 Million Partnership with Health Net and Centene Foundation
News Preview
Seniors in Azusa, California will have a home in a new 96-bed care facility, which will offer meals, mental health, medical care, and case management services to address their urgent needs.
SACRAMENTO, Calif., Oct. 1, 2025 /PRNewswire/ -- Health Net, one of Cali...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
01.10.2025
ISIN: GB0009223206
Smith & Nephew PLC
SN
LISTED
LSE
Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty
News Preview
Completes the CORIOGRAPH Services portfolio which also includes solutions for knee and hip arthroplasty...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
01.10.2025
ISIN: US2538252022
Hypha Labs, Inc.
FUNI
LISTED
OTC
Hypha Labs and Tryptomics Launch Phase II of Strategic Partnership, Pairing Patented Mushroom Accelerator(TM) with World-Class Internal Quality Control & Fungal Genomics
News Preview
LAS VEGAS, NV, NV / ACCESS Newswire / October 1, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company pioneering the development of functional mushroom technologies, today announced the official launch of Phase II in its strategic partnership with Tryptomics, uniting Hypha's patented Mushroom Accelerator™ platform with Tryptomics On-...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US05463X1063
AxoGen Inc
AXGN
LISTED
NASDAQ
AXGN Investors Have Opportunity to Join Axogen, Inc. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Axogen, Inc. (“Axogen” or “the Company”) (NASDAQ: AXGN) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
01.10.2025
ISIN: US18507C1036
Clearpoint Neuro Inc
CLPT
LISTED
NASDAQ
ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System
News Preview
New Product Category Will Enable Added Flexibility to Support Commercial Launches of Cell and Gene Therapy SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 1, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today f...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US37733W2044
GSK plc
GSK
LISTED
NYSE
New Local Data in GSK and IQVIA's Vaccine Track Supports Smarter Public Health Action at the Community Level
News Preview
GSK plc (LSE/NYSE: GSK) today announced a major update to Vaccine Track, a first-of-its-kind, interactive public data tool for tracking adult immunization activity in the US. Users can now explore vaccination trends across 387 different metro areas* to get insights on adult immunization at the local level. Vaccine Track now also includes a full de...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US48669G2049
Kazia Therapeutics Ltd
KZIA
LISTED
NASDAQ
Kazia Therapeutics Supports Australian MRFF-Funded Project Developing AI-Driven Sequential Therapy Strategy for DIPG/DMG
News Preview
SYDNEY, Oct. 1, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), a clinical-stage biotechnology company developing innovative therapies for brain cancers, today announced its participation in a fully funded Australian Medical Research Future Fund (MRFF) project titled "Sequential & Temporal Therapeutic Agility for the Treatment...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Illumina launches new business to accelerate technology and data-driven discovery
News Preview
New business focuses on developing data assets, software, and AI to
fuel life science breakthroughs
Expands pharma access to large omics datasets to
advance target discovery and drug development...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
01.10.2025
ISIN: US2307701092
Cumberland Pharmaceuticals, Inc.
CPIX
LISTED
NASDAQ
CUMBERLAND PHARMACEUTICALS ANNOUNCES PRODUCT APPROVAL IN MEXICO
News Preview
Injectable Ibuprofen Approved for Treating Pain & Fever
NASHVILLE, Tenn., Oct. 1 , 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced that its ibuprofen injection product, has received reg...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US92556V1061
Viatris Inc
VTRS
LISTED
NASDAQ
Viatris to Report Third Quarter 2025 Financial Results on November 6, 2025
News Preview
PITTSBURGH, Oct. 1, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) will report third quarter 2025 financial results on Thursday, November 6, 2025. Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.
Investors and the general public are invited to liste...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US38246G1085
GoodRx Holdings, Inc.
GDRX
LISTED
NASDAQ
GoodRx Launches Brand Medication Savings Program at National Retail Pharmacy
News Preview
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the availability of its brand medication savings solution, RxSmartSaver powered by GoodRx, at Kroger pharmacies nationwide. RxSmartSaver brings medication affordability directly to the pharmacy counter, improving the patient experience while delivering...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US30048L3024
Evofem Biosciences, Inc
EVFM
LISTED
OTC
Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates
News Preview
— First ex-U.S. Regulatory Filing for SOLSOEC® —
— Pharma 1 Targets 1H 2026 Launch in UAE for
SOLOSEC® to Treat Bacterial Vaginosis and Tricho...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US9467841055
Waystar Holding Corp.
WAY
LISTED
NASDAQ
Waystar Closes Acquisition of Iodine Software, Extending AI Leadership in Healthcare Software
News Preview
Unites industry-leading AI-powered financial and clinical intelligence on Waystar's cloud-based software platform
Expands total addressable market by more than 15%; expected to be accretive to financial profile with highly recurring subscription-based business...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LFMD LAWSUIT ALERT: Levi & Korsinsky Notifies LifeMD, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
News Preview
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. ("LifeMD, Inc." or the "Company") (NASDAQ: LFMD) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Investors in Altimmune, Inc. Should Contact Levi & Korsinsky Before October 6, 2025 to Discuss Your Rights - ALT
News Preview
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ: ALT) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Lost Money on Nutex Health Inc.(NUTX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
News Preview
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
November 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SVRA
News Preview
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
October 28, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SMLR
News Preview
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Semler Scientific, Inc. ("Semler Scientific, Inc." or the "Company") (NASDAQ: SMLR) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Levi & Korsinsky Reminds Lantheus Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 10, 2025 - LNTH
News Preview
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
Investors who lost money on Unicycive Therapeutics, Inc.(UNCY) should contact Levi & Korsinsky about pending Class Action - UNCY
News Preview
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. ("Unicycive Therapeutics, Inc." or the "Company") (NASDAQ: UNCY) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Class Action Filed Against Cytokinetics, Incorporated (CYTK) - November 17, 2025 Deadline to Join - Contact Levi & Korsinsky
News Preview
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US2290503075
Cryoport Inc
CYRX
LISTED
NASDAQ
Cryoport Systems Expands Global Footprint with New Global Supply Chain Center in Paris, France
News Preview
The 55,000-Square-Foot Facility is the Latest Addition to Cryoport Systems' Global Supply Chain Center Network
Designed to Support Complex Life Sciences Supply Chain Needs, Including Biologistics, BioServices and Future Cryopreservation Services Worldwide...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US04962H2094
Atossa Therapeutics, Inc.
ATOS
LISTED
NASDAQ
Atossa Therapeutics Names Janet R. Rea, MSPH, as Senior Vice President, R&D to Accelerate (Z)-Endoxifen Toward Key Regulatory Milestones
News Preview
Veteran development leader with successful regulatory approvals record returns to lead late-stage clinical and regulatory programs to address multiple unmet clinical needs
SEATTLE, Oct. 1, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS; "Atossa" or...
Themefolio
Profiler
Peergroup
© Newsfile
01.10.2025
ISIN: US33749P4081
Entero Therapeutics Inc
ENTO
LISTED
NASDAQ
ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand
News Preview
Transaction positions ENTO in the high-growth AI energy-infrastructure market, amid a surge of multi-billion-dollar hyperscaler spending on data centers, and rapid growth in behind-the-meter energy storage solutionsBoca Raton, Florida--(Newsfile Corp. - October 1, 2025) - Entero Therapeutics, Inc. (NASDAQ: ENTO) ("ENTO" or the "Company") today anno...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US0162551016
Align Technology, Inc.
ALGN
LISTED
NASDAQ
Align Technology to Announce Third Quarter 2025 Results on October 29, 2025
News Preview
Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2025 financial results on Wednesd...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US36266G1076
GE Healthcare Technologies Inc
GEHC
LISTED
NASDAQ
GE HealthCare to announce third quarter 2025 results on October 29, 2025
News Preview
GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2025 financial results before the market opens on Wednesday, October 29, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://invest...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US91324P1021
UnitedHealth Group Inc
UNH
LISTED
NYSE
UnitedHealthcare’s 2026 Medicare Advantage Plans Deliver Value, Access and Consumer Choice
News Preview
UnitedHealthcare® today introduced its 2026 Medicare Advantage plans, offering reliable coverage and benefits to meet the evolving needs of Medicare consumers. With more than 45 years of experience in serving Medicare beneficiaries and nearly two decades as the most chosen Medicare Advantage brand1, UnitedHealthcare remains focused on delivering v...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Altimmune, Inc. (NASDAQ: ALT) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
News Preview
PHILADELPHIA, Oct. 1, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Altimmune Inc. (NASDAQ: ALT) ("Altimmune" or the "Company") on behalf of investors who purchased or otherwise acquired publicly traded securities of Altimmune between August 10, 202...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Immunotherapeutics (MLTX) Faces Investor Scrutiny After Reporting Disappointing Phase 3 Trial Data For Lead Drug Candidate -- Hagens Berman
News Preview
SAN FRANCISCO, Oct. 1, 2025 /PRNewswire/ -- Investors in MoonLake Immunotherapeutics (NASDAQ: MLTX) saw the price of their shares crater $55.75, or about 90%, after the company announced disastrous VELA-2 trial results for sonelokimab, its highly anticipated treatment for patients with skin disease (hidradenitis...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
01.10.2025
ISIN: CA3686501071
Gemina Laboratories Ltd
GLAB
LISTED
CSE
Gemina Laboratories Announces Termination of Transaction
News Preview
VANCOUVER, BC / ACCESS Newswire / October 1, 2025 / Gemina Laboratories Ltd. (CSE:GLAB) (the "Company" or "Gemina") announces that further to its news release dated November 13, 2024, the Company will not be proceeding with the non-brokered private placement of up to $7,000,000 at a price of $0.75 per common share. The Company h...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Avantor® to Host Third Quarter 2025 Earnings Call on Wednesday, October 29, 2025
News Preview
RADNOR, Pa., Oct. 1, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its third quarter 2025 financial results before the market opens on Wednesd...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US81749D1072
Sera Prognostics Inc
SERA
LISTED
NASDAQ
Sera Prognostics Names Dr. Tiffany Inglis Chief Medical Officer
News Preview
SALT LAKE CITY, Oct. 1, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker testing to help deliver information to doctors and patients, today announced the appointment of Tiffany Inglis, M...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
BUYOUT INVESTIGATION: Does $28.00 Per Share Buyout Offer Shortchange STAAR Surgical Company (NASDAQ: STAA) Shareholders? Kaskela Law LLC is Investigating the Buyout Offer and Encourages STAA Shareholders to Contact the Firm
News Preview
PHILADELPHIA, Oct. 1, 2025 /PRNewswire/ -- The law firm of Kaskela Law LLC announces that it is investigating the shareholder buyout offer made to STAAR Surgical Company (NASDAQ: STAA) ("STAAR" or the "Company") investors to determine whether the proposal is fair and provides sufficient monetary consideration for...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US42227W2070
Healthcare Triangle Inc
HCTI
LISTED
NASDAQ
Healthcare Triangle Subsidiary QuantumNexis Reports $20M in Consumption-Based Revenue Processed on Ezovion Platform, Forecasts $37M Amid Rapid Growth
News Preview
PLEASANTON, Calif., Oct. 1, 2025 /CNW/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced a significant milestone for its wholly-owned subsidiary, QuantumNexis.
QuantumNexis's Ezovion...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: GB00BRS65X63
Indivior plc
INDV
LISTED
LSE
Indivior Proposes New Corporate Structure to Achieve U.S. Domiciliation
News Preview
RICHMOND, Va., Oct. 1, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) ("Indivior PLC" or the "Company") today announced that it intends to pursue a change in domicile from the U.K. to the U.S. and will establish a new U.S. parent company, Indivior Pharmaceuticals, Inc. (IPI), above its existing U.K. parent comp...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US42227W2070
Healthcare Triangle Inc
HCTI
LISTED
NASDAQ
Healthcare Triangle Subsidiary QuantumNexis Reports $20M in Consumption-Based Revenue Processed on Ezovion Platform, Forecasts $37M Amid Rapid Growth
News Preview
PLEASANTON, Calif., Oct. 1, 2025 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced a significant milestone for its wholly-owned subsidiary, QuantumNexis.
QuantumNexis's...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US28414H1032
Elanco Animal Health Inc
ELAN
LISTED
NYSE
Elanco Confirms Date and Conference Call for Third Quarter 2025 Financial Results Announcement
News Preview
GREENFIELD, Ind., Oct. 1, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its third quarter 2025 financial results on Wednesday, November 5, 2025. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's perfor...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
Natrelle® Awarded Supplier Agreement from Vizient
News Preview
This agreement grants Vizient clients enhanced access to Natrelle®, the broadest selection of breast implant options on the market.
IRVINE, Calif., Oct. 1, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced today that Natrelle® has been named a supplier by Vizient,...
Themefolio
Profiler
Peergroup
© Newsfile
01.10.2025
ISIN: CA71716H1082
PharmaTher Holdings Ltd.
PHRM
LISTED
CSE
PharmaTher Announces Sale of Ketamine ANDA with Potential to Generate over US$25 Million in Milestone and Profit-Sharing Payments
News Preview
Toronto, Ontario--(Newsfile Corp. - October 1, 2025) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, is pleased to announce that it has entered into a definitive Asset Purchase Agreement (the "Agreement") for the...
Themefolio
Profiler
Peergroup
© Newsfile
01.10.2025
ISIN: US29415V1098
Envoy Medical, Inc.
COCH
LISTED
NASDAQ
Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th
News Preview
White Bear Lake, Minnesota--(Newsfile Corp. - October 1, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced that management will participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) conferen...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US8835561023
Thermo Fisher Scientific Inc
TMO
LISTED
NYSE
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 22, 2025
News Preview
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2025 before the market opens on Wednesday, October 22, 2025, and will hold a conference call on the same day at 8:30 a.m. ET.
During the call, the company will discuss its financial performanc...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: GG00BMF1JR16
Genius Sports Limited
GENI
LISTED
NYSE
Bryan Castellani, Former Disney, ESPN and Warner Music Executive, Joins Genius Sports as Chief Financial Officer
News Preview
Genius Sports Limited (“Genius Sports”) (NYSE:GENI), the official data, technology and broadcast partner powering the global sports, betting and media ecosystem, today formally welcomes Bryan Castellani as Chief Financial Officer, effective immediately.
Based in the company’s New York office and reporting to Co-Founder and Chief Executive Office...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: CA23126M1023
Curaleaf Holdings Inc
CURA
LISTED
TSX
Curaleaf and The Baldwin Fund Partner to Raise Funds for Breast Cancer Research This October
News Preview
Curaleaf celebrates six years of its national at-register donation program for Breast Cancer Action Month
All contributions benefit The Carol M. Baldwin Breast Cancer Research Fund of CNY, also known as The Baldwin Fund...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: CA23126M1023
Curaleaf Holdings Inc
CURA
LISTED
TSX
Curaleaf and The Baldwin Fund Partner to Raise Funds for Breast Cancer Research This October
News Preview
Curaleaf celebrates six years of its national at-register donation program for Breast Cancer Action Month
All contributions benefit The Carol M. Baldwin Breast Cancer Research Fund of CNY, also known as The Baldwin Fund...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: INE376G01013
Biocon Ltd
BIOCON
LISTED
Biocon Biologics Secures U.S. Market Entry Date for Bosaya™ and Aukelso™, Denosumab Biosimilars
News Preview
BENGALURU, India and BRIDGEWATER, N.J., Oct. 1, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: BIOCON), today announced a settlement and license agreement with Amgen Inc. that clears the path for the commercializatio...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US02043Q1076
Alnylam Pharmaceuticals Inc
ALNY
LISTED
NASDAQ
Alnylam Announces First Patient Dosed in ZENITH Global Phase 3 Cardiovascular Outcomes Trial of Zilebesiran
News Preview
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the first patient has been dosed in ZENITH (ZilebEsiraN CardIovascular OuTcome Study in Hypertension), a global Phase 3 cardiovascular outcomes trial (CVOT) designed to evaluate the potential of zilebesiran, an investigational biannual subcuta...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US5898891040
Merit Medical Systems Inc
MMSI
LISTED
NASDAQ
Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology
News Preview
SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US98160J1088
MariMed Inc.
MRMD
LISTED
CSE
MariMed’s InHouse Brand Again Supports Veterans Facing Housing Challenges With Second Annual Help on the Homefront Campaign
News Preview
MariMed’s InHouse Brand Again Supports Veterans Facing Housing Challenges With Second Annual Help on the Homefront Campaign...
Themefolio
Profiler
Peergroup
© EQS Newswire
01.10.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer Expands Wertheim Site with new Production Facility for Ready-to-fill Vials
News Preview
Gerresheimer Expands Wertheim Site with new Production Facility for Ready-to-fill Vials
New production hall for RTF vials and innovative EZ-fill Smart packaging platform
Best possible protection for sensitive biologics
Total investment volume of around EUR 30 million
Around 50 new jobs for skilled workers from the region
Düsseldorf/Wertheim, Ge......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.10.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer erweitert Standort Wertheim für die Produktion von „ready-to-fill“ Injektionsfläschchen
News Preview
Gerresheimer erweitert Standort Wertheim für die Produktion von „ready-to-fill“ Injektionsfläschchen
Neue Produktionshalle für RTF-Fläschchen und innovative Verpackungsplattform EZ-fill Smart
Bestmöglichen Schutz für empfindliche Biopharmazeutika
Gesamtinvestitionsvolumen von rund 30 Mio. Euro
Rund 50 neue Arbeitsplätze für Fachkräfte aus de......
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
Aetna 2026 Medicare Advantage plans deliver access to affordable, personalized care
News Preview
Providing access to affordable care
$0 copays on Tier 1 drugs & covered vaccines at in-network pharmacies1,
$0 copay for colonoscopies and mammograms...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
ISIN: US59503A2042
Microbot Medical Inc.
MBOT
LISTED
NASDAQ
Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio
News Preview
Commercial Focus Remains on U.S. Market as it Continues to Explore Certain Global Markets that Accept FDA Cleared Devices ...
Themefolio
Profiler
Peergroup
© Newsfile
01.10.2025
ISIN: CA81752F1062
Sernova Biotherapeutics Inc
SVA
LISTED
TSX
Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang
News Preview
Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure for type 1 diabetes (T1D), today announced that it has signed debt-to-...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: JE00BYSS4X48
Novocure Ltd
NVCR
LISTED
NASDAQ
Novocure to Report Third Quarter 2025 Financial Results
News Preview
Novocure (NASDAQ: NVCR) will report financial results for the third quarter 2025 on October 30, 2025, before the U.S. financial markets open.
Novocure management will host a conference call and webcast at 8:00 a.m. EDT, October 30, to discuss the company’s financial results for the three- and nine-month periods that ended September 30, 2025.
T...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Humana’s 2026 Medicare Advantage Plans Prioritize Simplicity, Stability and Quality Care for Beneficiaries
News Preview
Humana Inc. (NYSE: HUM), a leading health and well-being company, today announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2026. During the Medicare Annual Election Period (AEP) Oct. 15-Dec. 7, Medicare beneficiaries may review plan changes for the coming year and select a plan to meet their evolving healthcare need...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
ISIN: JP3475350009
Daiichi Sankyo Co Ltd
45680
LISTED
XJPX
ENHERTU® Followed by THP Supplemental Biologics License Application Accepted in the U.S. for Patients with High-Risk HER2 Positive Early-Stage Breast Cancer Prior to Surgery
News Preview
Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) supplemental Biologics License Application (sBLA) for ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by paclitaxel, trastuzumab and pertuzumab (THP) has been accepted for review in the U.S. for the neoadjuvant treatment of adult patients with HER2 positive (IHC 3+ or ISH+) sta...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
